Signalling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes

Abstract excerpt

End-stage liver disease can be the termination of acute or chronic liver diseases, with manifestations of liver failure; transplantation is currently an effective treatment for these. However, transplantation is severely limited due to the serious lack of donors, expense, graft rejection and requirement of long-term immunosuppression. Mesenchymal stem cells (MSCs) have attracted considerable attention as...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Liver physiology and pathology
• Share to Mesenchymal stem cell research
• Share to Organ Transplantation Techniques and Outcomes